Genomize is an established global bioinformatics company founded in 2014 with the slogan "Scientific excellence for everyone." Specializing in the analysis of genomic data, Genomize's SEQ platform focuses on the analysis of Next Generation Sequencing (NGS) data. This platform provides a comprehensive solution from raw data to clinical report generation, automates data transfer and back-up, offers tools for data and organization management, and enables detailed bioinformatics analysis accessible from any device connected to the internet. The company has processed more than 200,000 samples from more than 300 centers in more than 20 countries, with hospitals, genetic diagnosis centers, and research institutes counting SEQ as their core bioinformatics solution. It operates within the industries of Big Data, Biotechnology, Health Care, Internet, IoT, Life Sciences, and Robotics, with its headquarters in Turkey. Despite the provided information, there are no details available regarding the latest investment or associated investors.
There is no investment information
No recent news or press coverage available for Genomize.